EW   $70.38  1.22% Market Closed After Close 70.5 0.17%

Edwards Lifesciences Corp
Total Cash 1.99B
totalCashPerShare 3.303
EBITDA 2.06B
Total Debt 693.00M
quickRatio
currentRatio
Total Revenue 6.31B
debtToEquity 9.234
Revenue/Share 10.498
ROA
ROE
grossProfits
freeCashflow
operatingCashflow
earningsGrowth 7.16
revenueGrowth -0.085
grossMargins 0.766
ebitdaMargins 0.32599
operatingMargins 0.29113
profitMargins 0.65859
enterpriseValue 38.94B
forwardPE 27.22041
floatShares 596.35M
sharesOutstanding 602.40M
sharesShort 8.22M
sharesShortPriorMonth 11.38M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.86%
Short Ratio help_outline 1.15%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 12.348
Price To Book help_outline 5.40
earningsQuarterlyGrowth 6.98
netIncomeToCommon 1.57B
trailingEps 2.36%
forwardEps 2.45%
enterpriseToEbitda 18.92
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.55 4Q 2024
institutionsCount 1777
lastUpdated Nov. 6, 2024, 3:32 p.m.